Kestra Medical Technologies, Ltd. Investment Income, Interest
Kestra Medical Technologies, Ltd. (KMTS) reported Investment Income, Interest of $2.13 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. investment income, interest for the quarter ending 2026-07-31 was $2.13M, a 1.94% decline year-over-year.
- Kestra Medical Technologies, Ltd. investment income, interest for the quarter ending 2026-04-30 was $2.23M, a 34.42% increase year-over-year.
- Kestra Medical Technologies, Ltd. investment income, interest for the quarter ending 2026-01-31 was $2.16M, a 244.43% increase year-over-year.
- Kestra Medical Technologies, Ltd. investment income, interest for the quarter ending 2025-10-31 was $1.80M, a 104.56% increase year-over-year.
- Kestra Medical Technologies, Ltd. investment income, interest for fiscal 2026 was $8.35M, a 161.05% increase from fiscal 2025.
- Kestra Medical Technologies, Ltd. investment income, interest for fiscal 2025 was $3.20M.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-07-31 | $2.13M 10-Q · filed 2026-09-14 | $4.35M derived: sum of 2 quarters · filed 2026-09-14 | $6.51M derived: sum of 3 quarters · filed 2026-09-14 | $8.31M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $4.39M derived: sum of 2 quarters · filed 2026-07-14 | $6.18M derived: sum of 3 quarters · filed 2026-07-14 | $8.35M 10-K · filed 2026-07-14 |
| 2026-01-31 | $2.16M 10-Q · filed 2026-03-17 | $3.96M derived: sum of 2 quarters · filed 2026-03-17 | $6.13M 10-Q · filed 2026-03-17 | $7.78M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $1.80M 10-Q · filed 2025-12-11 | $3.96M 10-Q · filed 2025-12-11 | $5.62M derived: sum of 3 quarters · filed 2026-09-14 | $6.25M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $2.17M 10-Q · filed 2026-09-14 | $3.82M derived: sum of 2 quarters · filed 2026-09-14 | $4.45M derived: sum of 3 quarters · filed 2026-09-14 | $5.33M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.28M derived: sum of 2 quarters · filed 2026-07-14 | $3.16M derived: sum of 3 quarters · filed 2026-07-14 | $3.20M 10-K · filed 2026-07-14 |
| 2025-01-31 | $628.00K 10-Q · filed 2026-03-17 | $1.51M derived: sum of 2 quarters · filed 2026-03-17 | $1.54M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | $878.00K 10-Q · filed 2025-12-11 | $915.00K 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | $37.00K 10-Q · filed 2025-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |